The early diagnosis of rheumatoid arthritis (RA) has become a priority owing to the availability of effective disease-modifying agents that can improve patient wellbeing and influence the clinical outcome...
Keywords: anti-cyclic citrullinated peptide (CCP) antibodies, citrullinated peptides, filaggrin, rheumatoid arthritis
02/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter